Structures by: McClenaghan I.

Total: 67

Α-Ammonium-α-methylpropionoate

NH41,C4H5O21

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o706-o707

a=10.6273(8)Å   b=9.0102(8)Å   c=11.3370(7)Å

α=90.00°   β=93.749(6)°   γ=90.00°

Benzocaine

C9H11NO2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o708-o709

a=8.198(2)Å   b=5.4300(10)Å   c=19.592(5)Å

α=90.00°   β=91.350(6)°   γ=90.00°

Ethyl 4-phenyl-2-(N-pyrrole)-1,3-thiazole-5-carboxylate

C16H14N2O2S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o745-o746

a=10.2375(4)Å   b=3.9460(2)Å   c=35.075(2)Å

α=90.00°   β=91.979(2)°   γ=90.00°

3-(4-(Methylsulfonyl)benzoyl)propionic acid

C11H12O5S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o729-o730

a=5.18510(10)Å   b=10.5030(3)Å   c=10.9550(4)Å

α=96.9900(10)°   β=101.1350(10)°   γ=101.786(3)°

Ethyl 4-tert-butyl-2-(3-phenylureido)-1,3-thiazole-5-carboxylate

C17H21N3O3S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o733-o734

a=6.1391(4)Å   b=9.9755(6)Å   c=28.248(2)Å

α=90.00°   β=90.00°   γ=90.00°

2-(N,N-Dimethylaminomethyl)-4-hydroxy-4-phenyl-2-thiazoline

C12H15ClN2OS

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o710-o711

a=6.1186(8)Å   b=9.3865(9)Å   c=11.977(2)Å

α=103.473(4)°   β=97.274(5)°   γ=93.320(10)°

Diethyl (4-tert-butyl-1,3-thiazol-2-ylaminomethylene)malonate

C15H23N2O4S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2003) 59, 2 o242-o243

a=19.663(4)Å   b=13.177(3)Å   c=13.708(3)Å

α=90.00°   β=103.69(3)°   γ=90.00°

2-Amino-4-(4-chlorophenylthio)-5-phenyl-6-(1-piperidyl)pyrimidine

C21H21ClN4S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2003) 59, 2 o222-o224

a=14.645(3)Å   b=6.4302(13)Å   c=20.954(4)Å

α=90.00°   β=98.67(3)°   γ=90.00°

2-(4-Methoxyphenyl)-5-(4-methylpent-3-enyl)-2,3,3a,4,7,7a-hexahydro- 1H-isoindole-1,3-dione

C21H25NO3

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2003) 59, 2 o198-o199

a=17.001(2)Å   b=6.5492(10)Å   c=17.145(3)Å

α=90.00°   β=110.584(5)°   γ=90.00°

2-Chloro-3-(3-dimethylaminopropylamino)-1,4-naphthoquinone

C15H17ClN2O2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2003) 59, 9 o1427-o1428

a=8.0693(8)Å   b=13.0020(10)Å   c=13.931(2)Å

α=90.00°   β=105.623(4)°   γ=90.00°

4-Chloro-2-methylthio-6-(piperidin-1-yl)pyrimidine

C10H14ClN3S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 3 o200-o201

a=13.189(3)Å   b=8.577(2)Å   c=20.195(4)Å

α=90.00°   β=90.00°   γ=90.00°

4,6-Dichloro-2-methylthio-5-phenylpyrimidine

C11H8Cl2N2S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 3 o264-o265

a=7.467(2)Å   b=16.217(3)Å   c=19.318(4)Å

α=90.00°   β=90.00°   γ=90.00°

6-Chloro-2-methylthio-4-[(2-phenylethyl)amino]pyrimidine

C26H28Cl2N6S2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 3 o198-o199

a=20.038(4)Å   b=11.358(2)Å   c=12.043(2)Å

α=90.00°   β=92.03(3)°   γ=90.00°

1-(3-Chloro-4-methylphenyl)pyrroline-2,5-dione

C11H8ClNO2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 2 o147-o148

a=10.473(2)Å   b=24.303(5)Å   c=3.8594(8)Å

α=90.00°   β=90.00°   γ=90.00°

2-Chloro-3-(4-methylpiperizino)-1,4-naphthoquinone

C15H15ClN2O2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 3 o287-o288

a=12.379(3)Å   b=9.389(2)Å   c=12.995(3)Å

α=90.00°   β=116.60(3)°   γ=90.00°

N-(4-Acetylphenyl)maleamic acid

C12H11NO4

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 6 o678-o679

a=5.5577(3)Å   b=25.5016(14)Å   c=7.4588(5)Å

α=90.00°   β=95.134(2)°   γ=90.00°

3-Cyano-6-(4-methoxyphenyl)-2(1H)-pyridone

C13H10N2O2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 6 o680-o681

a=10.6650(7)Å   b=9.8140(8)Å   c=11.1544(12)Å

α=90.00°   β=108.833(3)°   γ=90.00°

4-Methyl-2-(8-quinolyl)phthalazin-1-one

C18H13N3O

Lynch, Daniel E.Ian McClenaghan

Acta Crystallographica Section E (2002) 58, 10 o1051-o1052

a=7.9530(4)Å   b=8.4914(6)Å   c=10.8850(7)Å

α=77.060(6)°   β=74.114(5)°   γ=86.277(3)°

2-phenylpyrrolo[2,3-h]quinoline dihydrate

C17H12N2,2H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 10 o1150-o1151

a=24.758(4)Å   b=24.758(4)Å   c=4.6952(9)Å

α=90.00°   β=90.00°   γ=90.00°

2-(Benzoylmethylsulfanyl)-6-methoxy-1H-benzimidazole

C16H14N2O2S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2004) 60, 3 o363-o364

a=5.7681(3)Å   b=9.8914(6)Å   c=24.4281(16)Å

α=90.00°   β=96.798(3)°   γ=90.00°

2-Chloro-3-[4-(ethoxycarbonyl)-1-piperidyl]-1,4-naphthoquinone

C18H18ClNO4

Lynch, Daniel E.McClenaghan, IanColes, Simon J.

Acta Crystallographica Section E (2001) 57, 2 o125-o126

a=12.780(3)Å   b=16.931(3)Å   c=7.8532(16)Å

α=90.00°   β=101.85(3)°   γ=90.00°

5-tert-butyl-4-nitro-1H-pyrazol-3-ol

C7H11N3O3

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2005) 61, 8 o2347-o2348

a=6.4870(5)Å   b=6.6560(4)Å   c=11.5588(8)Å

α=81.227(4)°   β=76.733(3)°   γ=65.037(5)°

5-tert-Butyl-4-bromo-1,2-dihydro-1H-pyrazol-3(2H)-one monohydrate

C7H11BrN2O,H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2005) 61, 8 o2349-o2351

a=13.6840(4)Å   b=13.6840(4)Å   c=21.4734(8)Å

α=90.00°   β=90.00°   γ=90.00°

4-Hydroxy-6-methyl-2-(sulfonatoethylsulfanyl)pyrimidin-1-ium monohydrate

C7H10N2O4S2,H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2004) 60, 3 o376-o377

a=6.1137(2)Å   b=11.2202(3)Å   c=15.9632(6)Å

α=90.00°   β=91.0483(18)°   γ=90.00°

8-(2-Phenylethylamino)quinoline

C17H16N2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o4-o5

a=10.1202(3)Å   b=9.9645(3)Å   c=13.8592(5)Å

α=90.00°   β=110.7743(11)°   γ=90.00°

4-Amino-6-imidium-1,3,5-dithiazol-4-ene iodide

C3H6N3S21,I1

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o70-o71

a=11.050(2)Å   b=18.964(4)Å   c=8.1307(16)Å

α=90.00°   β=108.87(3)°   γ=90.00°

11H-Pyridinium[2,3h]-7,8,9,10-tetrahydrocarbazole chloride

C15H15N21,Cl1

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o43-o44

a=15.9111(6)Å   b=5.0374(2)Å   c=17.1233(9)Å

α=90.00°   β=113.9330(17)°   γ=90.00°

4-Methoxy-3-nitropyridinium chloride

C6H7N2O31,Cl1

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o83-o84

a=10.6185(4)Å   b=7.1517(4)Å   c=11.3701(5)Å

α=90.00°   β=111.523(3)°   γ=90.00°

8-(Isoindol-1,3-dione-2-yl)aminoquinoline

C17H11N3O2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o16-o17

a=16.397(3)Å   b=10.819(2)Å   c=7.6737(15)Å

α=90.00°   β=90.00°   γ=90.00°

2-Amino-4,6-bis(4-chlorophenylthio)pyrimidine

C32H22Cl4N6S4

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o11-o12

a=28.4777(13)Å   b=8.6020(3)Å   c=14.2055(5)Å

α=90.00°   β=102.5620(13)°   γ=90.00°

2-Amino-5-(4-methoxybenzyl)-4-methyl-1,3-thiazolium chloride

C12H15ClN2OS

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o24-o25

a=7.5746(15)Å   b=11.878(2)Å   c=14.519(3)Å

α=90.00°   β=100.47(3)°   γ=90.00°

2-Amino-4,6-bis(phenylthio)pyrimidine

C16H13N3S2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o26-o27

a=8.7937(18)Å   b=8.3091(17)Å   c=21.148(4)Å

α=90.00°   β=95.73(3)°   γ=90.00°

2-Amino-4-chloro-6-(4-carbamoylpyperidinyl)pyrimidine hemihydrate

C10H15ClN5O,0.5H2O

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o50-o51

a=15.559(3)Å   b=9.3139(19)Å   c=16.493(3)Å

α=90.00°   β=102.08(3)°   γ=90.00°

(E)-1-(2-Thienyl)ethanone 8-quinolylhydrozone

C15H13N3S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o52-o53

a=10.148(2)Å   b=14.251(3)Å   c=18.103(4)Å

α=90.00°   β=90.00°   γ=90.00°

2-Chloro-4-methylquinoline

C10H8ClN

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section E (2001) 57, 1 o54-o55

a=12.721(3)Å   b=7.8961(16)Å   c=16.617(3)Å

α=90.00°   β=90.00°   γ=90.00°

2-(4-Pyridyl)pyrrolo[3,2-h]quinoline

C32H22N6

Lynch, Daniel E.McClenaghan, IanLight, Mark E.

Acta Crystallographica Section E (2001) 57, 1 o56-o57

a=19.3539(8)Å   b=6.8609(3)Å   c=19.3579(8)Å

α=90.00°   β=112.325(2)°   γ=90.00°

Thiazolidine-2,4-dione

C3H3NO2S

Lynch, Daniel E.McClenaghan, IanLight, Mark E.

Acta Crystallographica Section E (2001) 57, 1 o79-o80

a=7.2926(2)Å   b=9.3642(3)Å   c=13.1208(5)Å

α=90.00°   β=90.00°   γ=90.00°

2-tert-Butyl-4,6-dinitrophenol

C10H12N2O5

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2004) 60, 8 o1288-o1289

a=9.974(2)Å   b=10.575(2)Å   c=11.547(2)Å

α=90.00°   β=112.90(3)°   γ=90.00°

Ethyl 2-(2-chloro-1,4-dihydro-1,4-dioxonaphthalen-3-ylamino)-4-phenylthiazole-5- carboxylate

C22H15ClN2O4S

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2005) 61, 3 o790-o791

a=19.191(5)Å   b=7.719(2)Å   c=12.640(3)Å

α=90.00°   β=94.845(18)°   γ=90.00°

Diethyl 2-aminothiazole-4,5-dicarboxylate hemihydrate

C9H12N2O4S,0.5H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2005) 61, 4 o824-o826

a=16.7835(4)Å   b=8.4580(2)Å   c=18.0373(5)Å

α=90.00°   β=111.6530(10)°   γ=90.00°

2-Amino-4-(pyrid-4-yl)pyrimidine

C9H8N4

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section C (2001) 57, 7 830-832

a=9.450(2)Å   b=13.689(3)Å   c=6.4390(10)Å

α=90°   β=103.35(3)°   γ=90°

2-Amino-4-(pyrid-4-yl)pyrimidine 4-aminobenzoic acid

C9H8N4,C7H7NO2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section C (2001) 57, 7 830-832

a=7.881(2)Å   b=26.354(5)Å   c=7.297(2)Å

α=90°   β=102.04(3)°   γ=90°

2-Amino-6-chloro-4-(1-phenylethylamino)pyrimidine

C12H13ClN4

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2000) 56, 11 e534-e534

a=17.4851(7)Å   b=17.4851(6)Å   c=16.2878(9)Å

α=90.00°   β=90.00°   γ=90.00°

4-Anilino-3-nitropyridine

C11H9N3O2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2000) 56, 11 e535-e535

a=9.9036(2)Å   b=19.9452(4)Å   c=13.6660(3)Å

α=90.00°   β=133.5610(10)°   γ=90.00°

4,6-Dichloro-2-methylthiopyrimidine

C5H4Cl2N2S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2000) 56, 11 e536-e536

a=13.6482(2)Å   b=14.1294(2)Å   c=14.1343(2)Å

α=119.9578(7)°   β=95.9391(6)°   γ=92.8349(7)°

C16H14N4

C16H14N4

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica, Section C (2002) 58, o642-o644

a=10.1678(4)Å   b=11.2970(6)Å   c=11.3566(6)Å

α=90°   β=90.284(3)°   γ=90°

C15H14N4

C15H14N4

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica, Section C (2002) 58, o642-o644

a=10.690(2)Å   b=5.5066(11)Å   c=21.363(4)Å

α=90°   β=90°   γ=90°

2-(pyrrolidin-1-yl)-1,4-naphthoquinone

C14H12.95Cl0.05NO2

Lynch, Daniel E.Ian McClenaghan

Acta Crystallographica Section C (2002) 58, 12 o704-o707

a=11.5759(5)Å   b=9.3063(4)Å   c=11.5275(4)Å

α=90°   β=118.896(2)°   γ=90°

2-(phenylthio)-3-(pyrrolidin-1-yl)-1,4-naphthoquinone

C20H17NO2S

Lynch, Daniel E.Ian McClenaghan

Acta Crystallographica Section C (2002) 58, 12 o704-o707

a=13.205(3)Å   b=11.387(2)Å   c=11.220(2)Å

α=90°   β=93.12(3)°   γ=90°

2-amino-6-chloropurine

C5H4ClN5

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section C (2003) 59, 1 o53-o56

a=7.0855(10)Å   b=7.0855(10)Å   c=26.990(5)Å

α=90.00°   β=90.00°   γ=90.00°

2-amino-6-(4-chlorophenylthio)purine hemihydrate

C11H8ClN5S,0.5H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section C (2003) 59, 1 o53-o56

a=13.353(3)Å   b=7.743(2)Å   c=47.600(10)Å

α=90.00°   β=95.85(3)°   γ=90.00°

2-amino-6-(4-methylphenylthio)purine 1/3hydrate

C12H11N5S,0.333H2O

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section C (2003) 59, 1 o53-o56

a=10.8074(2)Å   b=11.6355(3)Å   c=15.3922(3)Å

α=85.468(2)°   β=83.2650(10)°   γ=79.7992(9)°

6-Methylimidazo[2,1-b]thiazole 2-amino-1,3-thiazole

C6H6N2S,C3H4N2S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2004) 60, 8 o592-o594

a=6.9195(2)Å   b=9.1860(2)Å   c=9.6953(3)Å

α=69.5204(17)°   β=71.4823(16)°   γ=74.2770(17)°

1-[4-nitro-2-(trifluoromethyl)phenyl]-4-phenylpiperazine

C17H16F3N3O2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section C (2004) 60, 1 o1-o5

a=13.390(3)Å   b=9.853(2)Å   c=12.503(3)Å

α=90°   β=102.97(3)°   γ=90°

1-[2-nitro-4-(trifluoromethyl)phenyl]-4-phenylpiperazine

C17H16F3N3O2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section C (2004) 60, 1 o1-o5

a=30.6687(12)Å   b=9.9731(3)Å   c=10.4592(3)Å

α=90°   β=95.8496(10)°   γ=90°

4-[4-nitro-2-(trifluoromethyl)phenyl]piperazine-1-carboxylate

C14H16F3N3O4

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section C (2004) 60, 1 o1-o5

a=12.555(3)Å   b=7.2688(15)Å   c=17.366(4)Å

α=90°   β=107.85(3)°   γ=90°

4-[2-nitro-4-(trifluoromethyl)phenyl]piperazine-1-carboxylate

C14H16F3N3O4

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section C (2004) 60, 1 o1-o5

a=8.8211(18)Å   b=11.717(2)Å   c=15.528(3)Å

α=86.55(3)°   β=81.97(3)°   γ=90.00(3)°

Ethyl-2-amino-4-phenyl-1,3-thiazole-5-carboxylate

C12H12N2O2S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2000) 56, 12 e586-e586

a=10.3124(2)Å   b=8.6888(3)Å   c=13.3156(3)Å

α=90.00°   β=97.2427(15)°   γ=90.00°

4-(Phenyl)thiosemicarbazide

C7H9N3S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2000) 56, 12 e587-e587

a=11.9231(7)Å   b=5.4888(3)Å   c=12.3788(8)Å

α=90.00°   β=91.527(3)°   γ=90.00°

2-Chloro-3-pyrrolidino-1,4-naphthoquinone

C14H12ClNO2

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2000) 56, 12 e588-e588

a=11.2926(6)Å   b=10.4429(4)Å   c=11.2028(4)Å

α=90.00°   β=115.829(15)°   γ=90.00°

2-phenylmalonpiperadide

C19H26N2O2

Lynch, Daniel E.Spicer, Gillian E.McClenaghan, Ian

Acta Crystallographica Section C (2003) 59, 12 o715-o718

a=6.1652(3)Å   b=10.2718(5)Å   c=26.1962(17)Å

α=90°   β=90°   γ=90°

2-phenylmalonmorpholide

C17H22N2O4

Lynch, Daniel E.Spicer, Gillian E.McClenaghan, Ian

Acta Crystallographica Section C (2003) 59, 12 o715-o718

a=8.39000(10)Å   b=10.8464(2)Å   c=17.0838(4)Å

α=90°   β=90°   γ=90°

2-Acetamido-4-p-tolyl-1,3-thiazole

C12H12N2OS

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2004) 60, 11 o815-o817

a=3.9541(5)Å   b=37.484(5)Å   c=7.7173(9)Å

α=90.00°   β=99.338(2)°   γ=90.00°

2-amino-4-tolyl-1,3-thiazolium chloride dihydrate

C10H11N2S,Cl,2H2O

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2004) 60, 11 o815-o817

a=6.8815(6)Å   b=9.3072(14)Å   c=19.499(3)Å

α=90.00°   β=90.00°   γ=90.00°

5-(4-Fluorophenyl)-1-phenylpyrazole

C15H11FN2

Daniel E. LynchIan McClenaghan

Acta Crystallographica Section E (2002) 58, 7 o731-o732

a=7.847(2)Å   b=7.904(2)Å   c=19.551(4)Å

α=90.20(3)°   β=100.92(3)°   γ=90.61(3)°

2-Chloro-3-(4-morpholino)-1,4-naphthoquinone

C14H12ClNO3

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2000) 56, 11 e537-e537

a=5.03860(10)Å   b=10.3948(2)Å   c=12.7421(3)Å

α=67.2038(12)°   β=84.4066(10)°   γ=81.2678(12)°

Ethyl 2-amino-4-tert-butyl-1,3-thiazole-5-carboxylate

C10H16N2O2S

Lynch, Daniel E.McClenaghan, Ian

Acta Crystallographica Section C (2004) 60, 8 o592-o594

a=10.6248(8)Å   b=8.6055(5)Å   c=13.0135(9)Å

α=90.00°   β=92.977(4)°   γ=90.00°